Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

  • You have access
    Preclinical pharmacokinetics evaluation of four novel 177Lu-labeled gastrin-releasing peptide receptor-targeted ligands: comparison with 177Lu-AMBA and 177Lu-RM2
    Lei Wang, Hsiou-Ting Kuo, Devon Chapple, Helen Merkens, Nadine Colpo, Pauline Ng, Wing Sum Lau, Ryan Wilson, Francois Benard and Kuo-Shyan Lin
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241134;
  • You have access
    Enhanced In Vivo Imaging through GPA33-Targeted Nanobody WWH347 Conjugated with 64Cu
    Jessica Hsu, Wenyu Song, Xiaoyan Li, Jonathan Engle, Weijun Wei and Weibo Cai
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241303;
  • You have access
    A Comparison Study of Dynamic 18F-Alfatide II Imaging and 11C-MET in Orthotopic Rat Models of Glioblastoma
    Yue Pan, Haodan Dang and Baixuan Xu
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241448;
  • You have access
    Successful reduction of renal retention for [68Ga]Ga-Z02176, a bradykinin B1 receptor-targeting peptide, by amino acid solution and fragmented albumin
    Chao-Cheng Chen, Hsiou-Ting Kuo, Helen Merkens, Joseph Lau, Francois Benard and Kuo-Shyan Lin
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241304;
  • You have access
    "Off-target(s)" for PSMA-targeted radioligands in the salivary glands?
    Will Julian, Olga Sergeeva, Wei Cao, Chunying Wu, Bernadette Erokwu, Christopher Flask, Xinning Wang, James Basilion, Sichun Yang and Zhenghong Lee
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241292;
  • You have access
    Enhanced Tumor Imaging and Therapeutic Potency using In Situ Site-Specific Self-Assembly of Modified Probes
    Jessica Hsu, Wenyu Song, Xiao Zhang, Zhaoguo Lin, Jonathan Engle, xiaoli Lan and Weibo Cai
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241302;
  • You have access
    A novel Ga-67-labeled Dual CA9-targeted Probe as a Potential radiopharmaceutical for Hypoxic Colorectal Cancer Diagnosis.
    Siao-Syun Guan, Yi-Hua Cai, Hung-Wen Yu and Ming-Wei Chen
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241088;
  • You have access
    Preliminary in vitro and in vivo evaluation of a theranostic radiolabeled PARP inhibitor for ovarian cancer
    Taylor Johnson, Jason Mixdorf, Todd Barnhart, Eduardo Aluicio-Sarduy, Manish Patankar, Sabrina Hoffman, Justin Jeffery, Justin Peikin, Jonathan Engle and Paul Ellison
    Journal of Nuclear Medicine June 1, 2023, 64 (supplement 1) P1515;
  • You have access
    Specific Activity of 225Ac-PSMA Targeting Agents Impacts Biodistribution in Prostate Cancer Tumor Model
    Anna Thickens, Nathan Clemons, Amanda Carston, Yadira Medina Guevara, Liudmila Lambert, Anatoly Pinchuk and Reinier Hernandez
    Journal of Nuclear Medicine June 1, 2023, 64 (supplement 1) P1568;
  • You have access
    Development of 43Sc/47Sc-PSMA-617 as Theranostics for Prostate Cancer: Preliminary In Vivo Molecular Imaging and Ex-Vivo Biodistribution in LNCaP Mouse Tumors
    Jason Meier, Mohammed Bhuiyan, Hannah Zhang, Hsiu-Ming Tsai, Lara Leoni, Megan Mendez, Phillip Selman, Pavithra Kankanamalage, Thomas Brossard, Jerry Nolen, Richard Freifelder, Walter Stadler, Ralph Weichselbaum, Chien-Min Kao, Raymond Moellering, Kaustab Ghosh, Antonino Pusateri, David Rotsch, Russell Szmulewitz and Chin-Tu Chen
    Journal of Nuclear Medicine June 1, 2023, 64 (supplement 1) P1553;

Pages

  • Previous
  • Next
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 15
SNMMI

© 2025 SNMMI

Powered by HighWire